Updates in HF and CAD

Updated:Apr 29,2011

Hospital Performance and Outcomes

  • The quality in health care delivery has been shown to play a role in hospital performance.
  • Study results suggest that hospitals with improved process of care have better rates for AMI and HF.
  • Hospitals participating in The Get With The Guidelines Program may improve the process of care for patients suffering from an AMI and HF.

Supporting Materials

Aldosterone Antagonist and HF

  • Data supports the use of aldosterone antagonist use in heart failure patients.
  • Aldosterone antagonists are underutilized of aldosterone antagonists in eligible patients.
  • The GWTG Program has been shown to improve the appropriate use of aldosterone antagonist therapy in heart failure patients.

Supporting Materials

Quality Improvement Overtime and the GWTG-CAD Program

  • New  treatment guidelines from AHA and ACC for patients with coronary artery disease (CAD)
  • A treatment gap exists between clinical practice and use of guideline recommended therapies.
  • GWTG-CAD quality improvement program improves guideline adherence for patients hospitalized with CAD.

Supporting Materials

Risk Scores for In-Hospital Mortality

  • Risk models may be useful in predicting in-hospital mortality.
  • Patients hospitalized with heart failure (HF) provide a unique setting for the validation of such prognostic information collection.
  • The Get With The Guidelines-HF (GWTG-HF) program’s validated risk score has the potential to influence the quality of care provided to patients hospitalized with HF by informing decision making through routinely collected clinical data.

Supporting Materials

Quality Outcomes of Hospital Angioplasty Volume and STEMI Patients

  • Previous data has demonstrated a relationship between low volume procedure hospitals and higher rates of death.
  • Evidence suggests that there is no apparent relationship between in-hospital mortality and procedural volume for hospitals participating in the GWTG-CAD program.
  • Data from study suggests that merely measuring and reporting volume of a procedure is not a surrogate measure of quality or outcome.

Supporting Materials


Other Readings
Depta J, Cannon C, Fonarow G, Zhao X, Peacock F, Bhatt D. Patient characteristics associated with the choice of triple anti-thrombotic therapy in the setting of acute coronary syndromes. Am J Cardiol 2009;104:1171–1178

Piccini J, Hernandez A, Zhao X, Pate M, Lewis W, Peterson E, Fonarow G. Quality of Care for Atrial Fibrillation among Patients Hospitalized for Heart Failure. JACC. (online) 


Connect with AHA Science News

Follow AHAScience on Twitter (opens in new window)
Like AHA Science News on Facebook (opens in new window)

Professional Online Network

Connect with over 30,000 heart and stroke professionals.